Target intelligence / Profile preview

Ret finger protein-like 1 (RFPL1)

Target
RFPL1
Molecular classification
E3 ubiquitin protein ligase, RING finger protein, Other
01

Overview

Ret finger protein-like 1 (RFPL1) is a member of the RING-B30 protein family, characterized by a tripartite structure containing a RING finger domain, coiled-coil region, and B30-2 domain[3]. The RING finger motif enables it to act as an E3 ubiquitin ligase, catalyzing the transfer of ubiquitin to substrate proteins, leading to their proteasomal degradation[4][1]. RFPL1 is predicted to negatively regulate the G2–M cell cycle transition, possibly by promoting the proteasomal degradation of cyclin B1 (CCNB1) and cyclin-dependent kinase 1 (CDK1), thus preventing their accumulation during interphase[1][6]. It localizes to the cytoplasm. There are paralogs (RFPL2, RFPL3), and RFPL1 is associated with genetic conditions such as oculomotor nerve paralysis, but no clear evidence establishes its use as a therapeutic drug target. The broader RING finger protein family plays diverse biological roles—including ubiquitination, cell cycle regulation, and immune signaling—with involvement in multiple diseases, but RFPL1 itself does not appear to be a validated therapeutic target at this time[1][2][3].

Other names
Ret finger protein-like 1RFPL1RFPL1LRNF78RING finger protein 78
02

Biological functions

Negative regulation of G2/M transition of mitotic cell cyclePositive regulation of proteasomal ubiquitin-dependent protein catabolic processUbiquitin protein ligase activity
03

Disease associations

Cancer (general implication via RING finger family function)Neurodegenerative disease (general implication via RING finger family function)Immunological disease (general implication via RING finger family function)Oculomotor nerve paralysis (mentioned in genetic association)Third cranial nerve disease (mentioned in genetic association)Other

Beyond the preview

Go deeper on Ret finger protein-like 1 (RFPL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ret finger protein-like 1 (RFPL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call